Structure of serotonin receptors: molecular underpinning of receptor activation and modulation

Abstract

The structural basis of the regulation of serotonin (5-hydroxytryptamine, 5-HT) receptors by ligands and lipids is only emerging. A recent study by Xu and colleagues published in Nature addresses this issue by resolving five structures of 5-HT1 receptor–G protein complexes. These include 5-HT1A in the apostate, i.e. not bound to a ligand, 5-HT1A and 5-HT1D bound to serotonin or the atypical antipsychotic aripiprazole (for 5-HT1A), and 5-HT1E bound to its selective agonist BRL-54443. These highresolution structures and their comparison enable critical insights into the conformational basis of basal and ligand activation of 5HT1 receptors, the pan-agonism of serotonin, and the mechanisms for modulation of 5-HT1 receptors by lipids. Besides, the structural analysis reveals important determinants for ligand selectivity and drug recognition by 5-HT1 receptors (Fig. 1a). The five 5-HT1 receptor structures determined by Xu and colleagues display the canonical seven-TM fold of G-proteincoupled receptors (GPCRs) and are similar to a previously described 5-HT1B–G-protein complex. 2 For the structures in the active state, the cytoplasmic pocket of the 5-HT receptors is open for G-protein binding. The resolved structures provide new insight into the mechanism underlying the high constitutive activity of 5HT1A receptors: the ligand-binding site in the structure of the 5HT1A receptor in the apo-state is similar to the structure of the ligand-binding pocket in complex with serotonin. Critical for the structural similarity are water molecules that form hydrogen bonds with residues building the ligand-binding pocket, thus counterfeited polar functionalities of serotonin (Fig. 1b). Serotonin is an important neurotransmitter of the nervous system. It regulates a broad range of physiological functions including the control of body temperature, appetite, sleep, mood, and pain. Serotonin acts by activating a family of heterogeneously expressed 5-HT receptors, including both GPCRs and ion channels. The 5-HT receptors comprise seven distinct classes based on their structural and functional characteristics. Among them, the inhibitory G-protein-coupled serotonin receptors belonging to the 5-HT1 subgroup are key players in the pathophysiology of major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders . 5-HT1 receptors thus have emerged as important therapeutic targets. However, the development of highly selective drug candidates requires a detailed understanding of the molecular underpinnings that determine receptor activation and signaling. Xu and colleagues provide key insights into these molecular determinants. Across twelve 5-HT GPCRs, which all bind serotonin, only eight out of 22 amino acids are identical in the ligand-binding pocket. Because of this variability in the composition of the ligand-binding pocket, different residues in different 5-HT GPCR subtypes bind serotonin with similar affinities and functional responses, explaining the pan-agonism of serotonin. The cryo-electron microscopy structures further reveal how the 5-HT receptor modulators BRL-54443, aripiprazole, and 5carboxamidotryptamine (5-CT) act as agonists for different subsets of serotonin receptors. These and other data show that the resolved structures allow to explain the pharmacological properties of available drugs and eventually be used for the design of new potent and specific 5-HT receptor modulators for the treatment of psychiatric diseases. Structures of GPCRs often display bound phospholipids and cholesterol molecules, and multiple studies demonstrated the functional importance of specific interactions between lipids and GPCRs. For example, studies of rhodopsin have shown that both polyunsaturated fatty acids and phosphatidylethanolamines can act as ligands interacting with specific sites on the receptor. Moreover, the discovery of allosteric sites within GPCRs suggests that membrane lipids can bind to allosteric sites acting as ligands further underline the role of membrane–lipid interactions in regulating GPCR dynamics and functions. Xu et al. identified a phospholipid molecule at the interface between the 5-HT1A receptor and a G-protein (Fig. 1c). The reported electron density is best in agreement with the structure of the phospholipid phosphatidylinositol 4-phosphate (PtdIns4P). The binding of PtdIns4P to the interface might stabilize complex formation and thus contribute to the enhanced activity of the receptor–G-protein complex in the presence of PtdIns4P. Indeed, this was confirmed by mutagenesis and functional studies, which demonstrated that PtdIns4P significantly improves G-protein coupling and GTPase activity, thus boosting the receptor-mediated signaling. Noteworthy, other membrane lipids including phosphatidylethanolamine, phosphatidylcholine, phosphatidylglycerol, and phosphatidylserine also enhanced the 5-HT1A receptor-mediated activation of Gi protein, but to a lower extent, suggesting a specific role of PtdIns4P. Moreover, the interaction of the 5-HT1A receptor with PtdIns4P increased constitutive receptor activity, thus, functioning as a positive allosteric modulator. Two closely related phospholipids, phosphatidylinositol, and phosphatidylinositol 4,5-bisphosphate, could potentially bind the same cavity as PtdIns4P, in agreement with the observation that these two